Along the same line, blocking IL-17 has shown to attenuate pulmonary fibrosis in both silica and bleomycin-induced pulmonary fibrosis models in mice and to promote resolution of fibrosis [93, 147]. This evidence concerns the gene IL17A and pulmonary fibrosis.